Detalhe da pesquisa
1.
Cardio-renal-metabolic disease in primary care setting.
Diabetes Metab Res Rev
; 40(3): e3755, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38115715
2.
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization.
Circulation
; 142(12): 1205-1218, 2020 09 22.
Artigo
Inglês
| MEDLINE | ID: mdl-32955939
3.
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
Endocr Pract
; 27(6): 505-537, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34116789
4.
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Endocr Pract
; 26(10): 1196-1224, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33471721
5.
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study.
Diabetologia
; 62(6): 948-958, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30953107
6.
Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes.
Diabetes Obes Metab
; 21(4): 883-892, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30499237
7.
EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES.
Endocr Pract
; 25(2): 144-155, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30383495
8.
Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes.
Diabetes Obes Metab
; 20(12): 2821-2829, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29974618
9.
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT.
Endocr Pract
; 24(11): 995-1011, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30763128
10.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
Endocr Pract
; 24(3): 302-308, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29547046
11.
DCRM Multispecialty Recommendations in Patients With Heart Failure.
J Card Fail
; 28(11): 1642-1645, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35973620
12.
Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II.
Diabetes Obes Metab
; 19(7): 989-996, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28206704
13.
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Endocr Pract
; 23(1): 100-112, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27819772
14.
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.
Endocr Pract
; 23(11): 1345-1349, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-29190135
15.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.
Endocr Pract
; 23(12): 1472-1478, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29320641
16.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Endocr Pract
; 23(Suppl 2): 1-87, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28437620
17.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
Endocr Pract
; 23(4): 479-497, 2017 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28156151
18.
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
JAMA
; 318(1): 45-56, 2017 Jul 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28672317
19.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.
Endocr Pract
; 22(2): 231-61, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26848630
20.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Endocr Pract
; 22(6): 753-62, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27082665